Zetia has underperformed a vitamin according to the results of a new study. Zetia is taken by millions of Americans to lower LDL, when used in concert with statin drugs.
Get the full story...
Statin drugs, primarily focused at reducing cholesterol, have been found to aid in something on the minds of many people. Yes, statin drugs help people make it through a flu infection.
Get the full story...
A new weight-loss drug appears to also reverse the progress of diabetes and cholesterol. The drug, so far called fatostatin as stating drugs are the best-known for cholesterol control, could be a three-way magic bullet against obesity, cholesterol, and diabetes.
Get the full story...
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process.
Get the full story...
For most people, cholesterol problems mean its time for statin drugs. But if you would prefer to avoid prescription drugs, there's been an unproven alternative: red yeast rice.
Get the full story...
Is The Heart Attack Grill a shamefully dangerous business or a refreshingly honest departure from today's "health-conscious" restaurants?
Get the full story & video...
For the first time ever, a Michigan State University researcher has shown cholesterol crystals can disrupt plaque in a patient’s cardiovascular system, causing a heart attack or stroke.
Get the full story...
Statin prescription varies across geographic locations in Australia, demonstrating inequalities in healthcare.
Get the full story...
Having discovered how a lowly, single-celled fungus regulates its version of cholesterol, Johns Hopkins researchers are gaining new insight about the target and action of cholesterol-lowering drugs taken daily by millions of people to stave off heart attacks and strokes. Their work appears in the December issue of Cell Metabolism.
Get the full story...
A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor, which is responsible for removing the bad cholesterol (LDL-cholesterol) from the bloodstream, may be inhibited by a third protein, annexin A2.
Get the full story...
Did you read about the revolutionary study of the statin drug, Crestor? A story in the LA Times (reprinted in the Star Tribune) was almost breathless in its praise:
Get the full story...